Early Renal-Replacement Therapy May Reduce the All-Cause Mortality of Severe COVID-19: An Observational Cohort Study | Zendy

Jing Qian | Zendy; Mengjing Wang | Zendy; Huaizhou You | Zendy; Jianfeng Luo | Zendy; Shengqing Li | Zendy; Shu Chen | Zendy; Yijian Chen | Zendy; Xiantao Li | Zendy; Kangjie Wang | Zendy; Weichen Zhang | Zendy; Yuan Li | Zendy; Ni Li | Zendy; Jing Chen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early Renal-Replacement Therapy May Reduce the All-Cause Mortality of Severe COVID-19: An Observational Cohort Study

Author(s) -

Jing Qian,

Mengjing Wang,

Huaizhou You,

Jianfeng Luo,

Shengqing Li,

Shu Chen,

Yijian Chen,

Xiantao Li,

Kangjie Wang,

Weichen Zhang,

Yuan Li,

Ni Li,

Jing Chen

Publication year - 2022

Publication title -

blood purification

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.686

H-Index - 57

eISSN - 1421-9735

pISSN - 0253-5068

DOI - 10.1159/000524229

Subject(s) - renal replacement therapy , medicine , covid-19 , observational study , intensive care medicine , cohort , cohort study , disease , virology , outbreak , infectious disease (medical specialty)

The efficacy of renal-replacement treatment (RRT) remains to be validated in COVID-19. In this retrospective cohort study, we aimed to assess the efficacy of early initiation of RRT in intensive care unit (ICU) adults with severe COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research